PBLS:NASDAQ, Parabilis Medicines Inc.

PBLS stock overview

Parabilis Medicines Inc. (PBLS:NASDAQ) closed at $27.44 on November 20, 2026, down 0.67% on the day. The stock trades 35.4% below its 52-week high of $42.49 and 21.1% above its 52-week low of $22.66. Over the past year, it lost 13.2%. Parabilis Medicines Inc. is part of the Health Care sector.

Key figures

Price
$27.44
Day change
-0.67%
Volume
1,246,548
Average volume
961,612
Market cap
3B+
52-week range
$22.66 – $42.49
50-day average
$30.02
200-day average
$31.79

Price action over the past year

In 114 trading sessions since June 11, 2026, PBLS closed higher on 55 days (48%). Its best day was October 19, 2026 (+11.43%) and its worst was September 23, 2026 (-12.73%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

PBLS news

About Parabilis Medicines Inc.

Parabilis is a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease. Parabilis leverages its proprietary platform to pioneer a novel therapeutic modality, Helicons¿, which are stabilized helical peptides engineered to bind and precisely modulate proteins that have long been beyond the reach of conventional medicines.

Similar stocks

Find more stocks like PBLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.